Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.

Update: This story has been corrected to reflect the source of 12-month data for the PRO-Kinetic device. It comes from the previous ENERGY Registry study, and not from the BIOHELIX-1 study. Biotronik ...

Operators performed closed-chest bypass before TAVI in a high-risk patient with decompensated HF due to a failing aortic ...

CHICAGO.-- Northwestern's Bluhm Cardiovascular Institute recently enrolled its first subject in ABSORB III, a clinical trial to study a "disappearing" heart device for the treatment of coronary artery ...

In one of the longest studies to date in high-risk heart disease, researchers found no significant difference in death rates over more than 10 years—as well as in cases of heart attack or ...

A new generation of coronary artery stent that combines a biodegradable component with an ultrathin scaffold showed promising results compared with the current gold standard, in a large population of ...

The delivery of coronary artery stents is a procedure that affects over 1 million patients each year in the United States. With an aging population, the declining cost of stents and reimbursement ...

Nov. 2 (UPI) --For patients with stable angina, coronary artery stents may have more of a placebo effect than previously thought, researchers in England report in a new study. Researchers from the ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

DEAR DR. ROACH: I am 68 and in good shape; I work out daily. I had a few episodes of angina two to three years ago and started going to a cardiologist as a result. I have had quite a few tests done, ...

Researchers have created a new noninvasive technique for performing a type of artery bypass that may change the future of some coronary surgeries.

Results of a large-scale, multicenter study found that treatment with two thin-strut drug-eluting stents were both non-inferior to a durable polymer drug-eluting stent and showed favorable clinical ...